Quantitative Investment Management LLC Takes $8.55 Million Position in Imperva Inc (IMPV)
Quantitative Investment Management LLC purchased a new stake in shares of Imperva Inc (NYSE:IMPV) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 178,600 shares of the software maker’s stock, valued at approximately $8,546,000. Quantitative Investment Management LLC owned about 0.53% of Imperva as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. North Run Capital LP boosted its holdings in Imperva by 999.3% in the first quarter. North Run Capital LP now owns 750,000 shares of the software maker’s stock worth $30,788,000 after purchasing an additional 681,772 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in Imperva by 47.0% in the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after purchasing an additional 403,809 shares during the last quarter. BlackRock Inc. boosted its holdings in Imperva by 11.3% in the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after purchasing an additional 215,170 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in Imperva by 17.7% in the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after purchasing an additional 192,625 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec purchased a new stake in Imperva in the first quarter worth approximately $7,192,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares in the company, valued at $4,341,476.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.20% of the company’s stock.
Shares of Imperva Inc (NYSE:IMPV) opened at 44.40 on Friday. Imperva Inc has a 12 month low of $34.40 and a 12 month high of $57.24. The company’s market capitalization is $1.50 billion. The stock’s 50 day moving average is $44.17 and its 200 day moving average is $45.59.
Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. During the same period last year, the company posted ($0.23) earnings per share. The business’s quarterly revenue was up 28.6% on a year-over-year basis. On average, equities analysts predict that Imperva Inc will post $0.81 EPS for the current fiscal year.
IMPV has been the topic of several research reports. ValuEngine cut shares of Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Monness Crespi & Hardt raised their target price on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Evercore ISI set a $56.00 target price on shares of Imperva and gave the stock a “buy” rating in a report on Friday, July 28th. Stephens restated an “overweight” rating and issued a $61.00 target price (up previously from $53.00) on shares of Imperva in a report on Thursday, July 13th. Finally, Susquehanna Bancshares Inc initiated coverage on shares of Imperva in a report on Wednesday, June 7th. They issued a “positive” rating and a $60.00 target price on the stock. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $52.97.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NYSE:IMPV).
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.